← Back to Clinical Trials
Recruiting NCT07308561

NCT07308561 The Relationship Between Quality of Life, Anxiety Levels, and Attitudes Toward Artificial Intelligence Among Women Undergoing Infertility Treatment

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07308561
Status Recruiting
Phase
Sponsor Acibadem University
Condition Infertility, Female
Study Type OBSERVATIONAL
Enrollment 191 participants
Start Date 2025-10-23
Primary Completion 2026-10-23

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 45 Years
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 191 participants in total. It began in 2025-10-23 with a primary completion date of 2026-10-23.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Infertility affects approximately one in six individuals worldwide and is associated with significant psychological distress, particularly among women undergoing treatment. Increased anxiety levels are strongly linked to reduced quality of life during the infertility process. With the growing integration of artificial intelligence (AI) into healthcare, AI-based tools are increasingly used in infertility care to support decision-making and patient engagement. While many patients are familiar with AI technologies, individual attitudes toward AI may influence their acceptance and potential psychosocial benefits. This study aims to examine the relationship between attitudes toward artificial intelligence, anxiety levels, and quality of life among women undergoing infertility treatment.

Eligibility Criteria

Inclusion Criteria: * Women aged 18-45 years diagnosed with infertility (primary or secondary infertility). * Women undergoing infertility treatment and those who have experienced various treatment modalities (IUI, IVF, ICSI). * Women who voluntarily agree to participate in the study. * Women who are able to understand and speak Turkish. Exclusion Criteria: * Women with diagnosed psychological disorders (e.g., clinical depression, anxiety disorders). * Women who are not undergoing infertility treatment.

Contact & Investigator

Central Contact

Güzin Ünlü Suvari, M.Sc.

✉ guzin.unlu@acibadem.edu.tr

📞 +902165004429

Frequently Asked Questions

Who can join the NCT07308561 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Infertility, Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07308561 currently recruiting?

Yes, NCT07308561 is actively recruiting participants. Contact the research team at guzin.unlu@acibadem.edu.tr for enrollment information.

Where is the NCT07308561 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT07308561 clinical trial?

NCT07308561 is sponsored by Acibadem University. The trial plans to enroll 191 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology